biotech · Multiple Myeloma · Multiple Myeloma (MM) · CCCC
C4 Therapeutics
C4 Therapeutics clinical programs — 0 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
WATERTOWN, MA, USA HQ
2024 Founded
2 Employees
Public company Type
CCCC · NYSE Ticker
Company details
- Status
- Public
- HQ
- WATERTOWN, MA, USA
- Founded
- 2024
- Employees
- 2
- Programs
- 4
- Drugs
- 1
- Patents
- 24
C4 Therapeutics projects
0 ClinicalTrials.gov programs sponsored by C4 Therapeutics.
C4 Therapeutics has 0 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
No programs matched
Frequently asked questions
How many clinical projects does C4 Therapeutics have?
0 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.